Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Keryx Biopharmaceuticals, Inc.
(NQ:
KERX
)
7.890
USD
-0.160 (-1.99%)
Streaming Delayed Price
/ Updated:
3:24 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Keryx Biopharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
May 07, 2013
Keryx to Host Investor Conference Call on Wednesday, May 8, 2013 at 8:30am EDT
Read More
from
PR Newswire
Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results
May 06, 2013
Investor Conference Call to be held Wednesday, May 8, 2013 at 8:30am EDT
Read More
from
PR Newswire
Keryx Biopharmaceuticals and Nuance Communications Analysis: (NASDAQ: KERX), (NASDAQ: NUAN)
April 23, 2013
from
SBWire Direct - Latest Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- KERX
March 28, 2013
from
GlobeNewswire News Releases
Morning Research on Sanofi, Keryx Biopharma, VIVUS, and Array BioPharma
March 27, 2013
from
PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 2, 2013 to Seek a Lead Plaint
March 25, 2013
from
Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- KERX
March 22, 2013
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 2, 2013 to Seek a Lead Plaint
March 19, 2013
from
PR Newswire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Keryx Biopharmaceuticals, Inc. to Contact the Firm -- KERX
March 18, 2013
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 2, 2013 to Seek a Lead Plaint
March 18, 2013
from
Business Wire News Releases
Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
March 14, 2013
Presentation Scheduled for Monday, March 18th at 10:00 AM PT
Read More
from
PR Newswire
Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
March 13, 2013
from
PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
March 11, 2013
Keryx to Host Investor Conference Call Tomorrow, Tuesday, March 12, 2013 at 8:30am EDT
Read More
from
PR Newswire
Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
March 11, 2013
Investor Conference Call to be held Tomorrow, Tuesday, March 12, 2013 at 8:30am EDT
Read More
from
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of Keryx Biopharmaceuticals, Inc. of Upcoming Deadline - KERX
March 08, 2013
from
GlobeNewswire News Releases
Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech's Industry Success
March 08, 2013
Five Star Equities Provides Stock Research on Galena Biopharma and Keryx Biopharmaceuticals
Read More
from
Marketwired News Releases
Potential Buyouts, Stronger Pipelines, FDA Filings - Research Report on Keryx, Lilly, Baxter, Biogen Idec and Shire
March 06, 2013
from
PR Newswire
VFC's Stock House Stock Watch Wednesday, 6 March 2013
March 06, 2013
from
EmailWire.Com Press Releases
Investors Alert: Groupon (NASDAQ:GRPN), MGIC Investment Corp. (NYSE:MTG) and Keryx Biopharmaceuticals (NASDAQ:KERX)
March 04, 2013
from
SBWire Direct - Latest Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Keryx Biopharmaceuticals, Inc., and Certain Officers -- KERX
February 26, 2013
from
GlobeNewswire News Releases
Today's Technical View on Sanofi and Keryx: Pharma Companies Yield Strong Returns
February 26, 2013
from
PR Newswire
Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
February 22, 2013
Presentation Scheduled for Wednesday, February 27th at 2:15 PM ET
Read More
from
PR Newswire
KERX, KORS, GTE and BCRX - Pre-Market Briefing
February 14, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the WSA Financial Ltd.
Read More
from
Marketwired News Releases
High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
February 14, 2013
from
PR Newswire
Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving magicJack VocalTec LTD., Tellabs, Inc. and Keryx Biopharmaceuticals
February 13, 2013
from
Marketwired News Releases
Intra-Day Update on Selected Stocks: (NYSE:EWJ), (NASDAQ:KERX)
February 11, 2013
from
SBWire Direct - Latest Press Releases
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
February 08, 2013
from
PR Newswire
Harwood Feffer LLP Announces Investigation of Keryx Biopharmaceuticals, Inc.
February 08, 2013
from
PR Newswire
Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
February 08, 2013
from
PR Newswire
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 2, 2013 to Seek a Lead Plaintiff Position
February 07, 2013
from
Marketwired News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here